Know Labs Inc (KNW)

[tim00mike]

FYI - Know Labs Announces Close of Financing
$14.2 Million for Product Development, Clinical Testing and Preparation for Up List to a Major Exchange

https://www.ldmicro.com/profile/knwn/news/6029076261966372

Seattle, WA. – March 15, 2021 - OTCQB: KNWN
Know Labs, Inc., an emerging leader in non-invasive medical diagnostics, through its proprietary electromagnetic energy technology platforms, announced today that it has closed on $14.2 million of financing. The financing was largely led by existing investors and insiders.

The financing is another step in the Company’s plans to up list on a major exchange, either NASDAQ or the NYSE, and supports continuing development and clinical testing on its platform technology with its first focus on non-invasive blood glucose monitoring, and future FDA approval. The current financing provides sufficient capital so that management can ensure product development stays on track and an up list to a major exchange is event driven rather than driven by a need for capital.

As previously stated, the Company believes an up list to a major exchange will:

Provide additional opportunities to attract institutional and retail investors, allowing the Company to broaden its investor base in the United States and internationally;
Increase the visibility of the Company, its growth strategy, accomplishments and results to date;
Enable an aggressive growth strategy;
Increase liquidity of the Company's common shares; and
Raise the Company's overall profile and ultimately enhance shareholder value.

Product development and clinical testing remain focused on:
Relationships with internationally recognized clinical research institutions to perform laboratory-based validation testing to confirm internal test results;
Continued work on miniaturization of the Know Labs platform diagnostic technology, internal testing and refinement of the use of its trade secret algorithms for exacting determination of the platform’s first use in determining blood glucose levels;
Expanding the Company’s Intellectual Property portfolio;
Preparation for submitting the Know Labs technology to the FDA for approval of its non-invasive blood glucose monitoring technology; and
Providing support to its Particle subsidiary as it launches its disinfecting light bulb into the marketplace.